• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Acad Radiol . An Interpretable Chest CT Deep Learning Algorithm for Quantification of COVID-19 Lung Disease and Prediction of Inpatient Morbidity an

tetano

Editor, Senior Moderator
Acad Radiol


. 2022 Apr 4;S1076-6332(22)00200-8.
doi: 10.1016/j.acra.2022.03.023. Online ahead of print.
An Interpretable Chest CT Deep Learning Algorithm for Quantification of COVID-19 Lung Disease and Prediction of Inpatient Morbidity and Mortality


Jordan H Chamberlin[SUP] 1 [/SUP], Gilberto Aquino[SUP] 1 [/SUP], Uwe Joseph Schoepf[SUP] 2 [/SUP], Sophia Nance[SUP] 1 [/SUP], Franco Godoy[SUP] 1 [/SUP], Landin Carson[SUP] 1 [/SUP], Vincent M Giovagnoli[SUP] 1 [/SUP], Callum E Gill[SUP] 1 [/SUP], Liam J McGill[SUP] 1 [/SUP], Jim O'Doherty[SUP] 3 [/SUP], Tilman Emrich[SUP] 1 [/SUP], Jeremy R Burt[SUP] 1 [/SUP], Dhiraj Baruah[SUP] 1 [/SUP], Akos Varga-Szemes[SUP] 1 [/SUP], Ismail M Kabakus[SUP] 1 [/SUP]



Affiliations

Abstract

Rationale and objectives: The burden of coronavirus disease 2019 (COVID-19) airspace opacities is time consuming and challenging to quantify on computed tomography. The purpose of this study was to evaluate the ability of a deep convolutional neural network (dCNN) to predict inpatient outcomes associated with COVID-19 pneumonia.
Materials and methods: A previously trained dCNN was tested on an external validation cohort of 241 patients who presented to the emergency department and received a chest computed tomography scan, 93 with COVID-19 and 168 without. Airspace opacity scoring systems were defined by the extent of airspace opacity in each lobe, totaled across the entire lungs. Expert and dCNN scores were concurrently evaluated for interobserver agreement, while both dCNN identified airspace opacity scoring and raw opacity values were used in the prediction of COVID-19 diagnosis and inpatient outcomes.
Results: Interobserver agreement for airspace opacity scoring was 0.892 (95% CI 0.834-0.930). Probability of each outcome behaved as a logistic function of the opacity scoring (25% intensive care unit admission at score of 13/25, 25% intubation at 17/25, and 25% mortality at 20/25). Length of hospitalization, intensive care unit stay, and intubation were associated with larger airspace opacity score (p = 0.032, 0.039, 0.036, respectively).
Conclusion: The tested dCNN was highly predictive of inpatient outcomes, performs at a near expert level, and provides added value for clinicians in terms of prognostication and disease severity.

Keywords: Artificial Intelligence; COVID-19; Critical Care; Pulmonology; Thoracic Radiology.
 
Back
Top Bottom